Online inquiry

IVTScrip™ mRNA-Anti-IL4-α, CD124(Cap 0, Pseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ5273MR)

This product GTTS-WQ5273MR is a type of mRNA modified with Pseudo-UTP, which ecodes the monoclonal antibody that targets IL4-α gene. The antibody can be applied in Asthma research.

Specifications
Product type	mRNA
Modified bases	Pseudo-UTP
5' Cap	Cap 0
Species	Homo sapiens
RefSeq	NM_000589.4
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	3565
UniProt ID	P05112

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-IL4-α, CD124(Cap 0, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WQ5273MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ3617MR	IVTScrip™ mRNA-Anti-FGFR2, BAY 1179470(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	BAY 1179470
GTTS-WQ3706MR	IVTScrip™ mRNA-Anti-MSLN, BAY 2287409(Cap 1, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	BAY 2287409
GTTS-WQ8498MR	IVTScrip™ mRNA-Anti-ITGAL, hu1124(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	hu1124
GTTS-WQ9821MR	IVTScrip™ mRNA-Anti-BTLA, JS004(Cap 0, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	JS004
GTTS-WQ3780MR	IVTScrip™ mRNA-Anti-Factor VIIa substitute, BAY-86-6150(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	BAY-86-6150
GTTS-WQ13327MR	IVTScrip™ mRNA-Anti-TFPI, PF-06741086(Cap 0, 5-Methyl-CTP, 120 nt-poly(A))	mRNA	PF-06741086
GTTS-WQ5065MR	IVTScrip™ mRNA-Anti-C5, CaCP-29(Cap 1, Pseudo-UTP, 30 nt-poly(A))	mRNA	CaCP-29
GTTS-WQ1692MR	IVTScrip™ mRNA-Anti-Dabigatran, aDabi-Fab(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	aDabi-Fab

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST